Dilafor
PrivateLast Round
VC Round
Apr 23, 2019
Est. Valuation
$23.01M
Company Overview
Dilafor is a drug discovery company that develops pharmaceutical products aimed at minimizing the risk for maternal and fetal complications associated with labor.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dilafor Comparables
Compare Dilafor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pfizer | 73% | |
| Gedeon Richter Plc. | 66% | |
| Bayer AG | 62% | |
Dilafor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 23, 2019 | ||||
| VC Round | Sep 27, 2016 | ||||
| Corporate Funding | Oct 8, 2014 |
Dilafor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rosetta Capital | VC Round |
| The Foundation for Baltic and East European Studies | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 120% MoM.
- Jan 2, 2026
Monthly visitors increased 1169% MoM, reaching 1K.
Dilafor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dilafor's valuation, stock price, and market status.